To deliver a functional cure for all patients with type 1 diabetes and an important new therapy for patients with type 2 disease that require insulin to maintain control, ViaCyte is developing products with numerous advantages including a virtually
unlimited supply of cells manufactured under quality - controlled conditions, and a
potentially safer and more optimal route of administration.